Propanc has raised $100 million for cryptocurrency reserves and cancer therapy research.
BlockBeats News, November 11th, according to The Block, Propanc Biopharma, a US-listed biopharmaceutical company (Nasdaq stock code: PPCB), has announced that it has secured up to $100 million in funding from the family office Hexstone Capital, which is active in the Bitcoin, Ethereum, Solana, Dogecoin, and other digital asset spaces. The private placement transaction was structured through convertible preferred stock, with Propanc receiving an initial investment of $1 million and up to $99 million in additional funding over the next year.
The funds will be used to build Propanc's digital asset portfolio and accelerate the development of its flagship cancer therapy, PRP, which is currently scheduled to begin its first human trials in 2026. The company did not specify which digital assets it plans to acquire. The financing news did not halt the decline in Propanc's stock price. On Monday, PPCB's stock price fell by 4%, dropping below $1, with a cumulative decrease of 43% over the past month.
You may also like

Why Is BlackRock Investing $5 Billion in the SpaceX IPO?

Cryptocurrency market makers collectively seek change as it becomes increasingly difficult to make money

a16z Crypto Partner: Cash flow is the moat

Citibank releases "2030 Asset Tokenization Market Outlook": 6 major trends may create a $8.2 trillion market

The trillion-dollar valuation test: Are the three major super IPOs a celebration for tech stocks or a nightmare for the crypto market?

Morning Report | Digital Asset completes $355 million financing led by a16z Crypto; Meta completes operational separation from Manus

Morning News | CME Group launches Nasdaq Cryptocurrency Index futures; Asset management giant Janus Henderson strategically invests in Ethena

Bitcoin Layer 2 Network Botanix: Why Did We Choose to Dissolve?

Why did Oracle deliver the strongest financial report in history, yet its stock price fell?

When the P2P illicit funds from ten years ago turned into 60,000 bitcoins

Dialogue with OmenX Founder: Why does the prediction market need an evolution from "spot" to "derivatives"?

Galaxy in-depth report: Is Solana still worth paying attention to?

Young people in South Korea make a "final effort" in the epic bull market

The pricing controversy of Trade.xyz exposes the fatal weakness of Pre-IPO perpetual contracts

How much longer can Ethereum's last big buyer hold on?

World Cup 2026 Coming – WEEX Celebrates with $1M Prize Pool & Michael Owen Live

Morning Report | OpenAI has submitted an S-1 registration statement draft to the U.S. SEC; Morpho completes $175 million financing




